Clinical Trials Browser

Phase 1 × INDUSTRY × IMM-101 × Clear all

NCT01308762 2012-12-06

A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients

Phase 1 Completed

19 enrolled 10 charts

Melanoma